HALO position history
The shares of Halozyme Therapeutics (HALO) that PZENA INVESTMENT MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q1: 15,738 shares, $628K, <0.01% of portfolio, New
- 2022 Q2: not held, Exit
- 2022 Q3: not held
- 2022 Q4: 14,507 shares, $825K, <0.01% of portfolio, New
- 2023 Q1: 9,216 shares, $352K, <0.01% of portfolio, Reduce −36.5%
- 2023 Q2: not held, Exit
- 2023 Q3: not held
- 2023 Q4: not held
- 2024 Q1: not held
- 2024 Q2: not held
- 2024 Q3: not held
- 2024 Q4: not held
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: 4,107 shares, $301K, <0.01% of portfolio, New
- 2025 Q4: 4,278 shares, $288K, <0.01% of portfolio, Add +4.2%
- 2026 Q1: 4,049 shares, $262K, <0.01% of portfolio, Reduce −5.4%
- 2026 Q2: 4,049 shares, $317K, <0.01% of portfolio
- 2026 Q3: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|